Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality

被引：0
|
作者：
Montserrat Vera-Llonch
Derek Weycker
Andrew Glass
Sue Gao
Rohit Borker
Angie Qin
Gerry Oster
机构：
[1] Policy Analysis Inc (PAI),
[2] Kaiser Permanente Northwest,undefined
[3] Amgen Inc,undefined
来源：
BMC Cancer | / 11卷
关键词：
Cost; metastatic breast cancer; chemotherapy; burden of illness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
    Vera-Llonch, Montserrat
    Weycker, Derek
    Glass, Andrew
    Gao, Sue
    Borker, Rohit
    Qin, Angie
    Oster, Gerry
    BMC CANCER, 2011, 11
  • [2] Risk and Healthcare Costs of Chemotherapy-Induced Neutropenic Complications in Women with Metastatic Breast Cancer
    Weycker, Derek
    Edelsberg, John
    Kartashov, Alex
    Barron, Rich
    Lyman, Gary
    CHEMOTHERAPY, 2012, 58 (01) : 8 - 18
  • [3] Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US population
    Ray, Saurabh
    Bonthapally, Vijayveer
    McMorrow, Donna
    Bonafede, Machaon
    Landsman-Blumberg, Pamela
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2013, 2 (02) : 195 - 206
  • [4] Treatment satisfaction in women receiving palbociclib combination therapies for advanced/metastatic breast cancer
    Darden, Christina
    Mitra, Debanjali
    McSorley, David
    Davis, Kimberly
    Band, Juliet
    Iyer, Shrividya
    FUTURE ONCOLOGY, 2019, 15 (02) : 141 - 150
  • [5] Nutritional status of women with non-metastatic breast cancer receiving outpatient chemotherapy
    Marcarini, Julia Anhoque Cavalcanti
    Grippa, Wesley Rocha
    Neto, Luiz Claudio Barreto Silva
    Podesta, Olivia Perim Galva
    Bolsoni-Lopes, Andressa
    Nunes, Karolini Zuqui
    Lopes-Junior, Luis Carlos
    NUTRITION, 2024, 123
  • [6] Chemotherapy treatment for older women with metastatic breast cancer: What is the evidence?
    Debled, Marc
    Bellera, Carine
    Donamaria, Catherine
    Soubeyran, Pierre
    CANCER TREATMENT REVIEWS, 2011, 37 (08) : 590 - 598
  • [7] Weight Changes in Women Receiving Chemotherapy for Non-Metastatic Breast Cancer in Saudi Arabia
    Al-Hajeili, Marwan
    Trabulsi, Nora
    Makin, Manar A.
    Shibriq, Noor
    Alshelali, Reem
    Alghoraibi, Lubna
    Alhaidari, Raneem
    Alhazzani, Lujain
    Alzahrani, Amani S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [8] Information preferences of women receiving chemotherapy for breast cancer
    Cowan, C.
    Hoskins, R.
    EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (06) : 543 - 550
  • [9] Controversies of chemotherapy for the treatment of metastatic breast cancer
    Conte, Pier Franco
    Bengala, Carmelo
    Guarneri, Valentina
    EJC SUPPLEMENTS, 2007, 5 (01): : 11 - 16
  • [10] Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis
    Li, Nanxin
    Hao, Yanni
    Koo, Valerie
    Fang, Anna
    Peeples, Miranda
    Kageleiry, Andrew
    Wu, Eric Q.
    Guerin, Annie
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (04) : 414 - 423
12345